Nomura Securities Maintains a 'Buy' on Emerson (EMR); Supporting The Process

Nomura Securities maintains a 'Buy' on Emerson (NYSE: EMR) price target of $64.00.

Analyst, Shannon O'Callaghan, said, "We think Process is running even stronger than the company expected, and we think Process can drive Emerson to some of the best organic growth in the sector over the next few quarters. Total EMR organic sales for the single month of April were up 9%, exceeding the company’s forecast. The company indicated that May and June are trending on plan and backlog conversion will drive 4Q. This all lends support to EMR’s guidance amid heavy skepticism."

For an analyst ratings summary and ratings history on Emerson click here. For more ratings news on Emerson click here.

Shares of Emerson closed at $47.86 yesterday.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Lowe's (LOW) PT Lowered to $275 at Guggenheim
• Ross Stores, Inc. (ROST) PT Raised to $239 at UBS on Q2 Earnings Beat
• Baird Starts Eaton Corporation (ETN) at Outperform